Cure enters the best-of-three as the stronger recent performer in the 2026 GSL Season 2 group stage, sitting atop Group A with a 2-0 record and 4-1 map score after victories that showcased consistent Terran macro and timing attacks. sOs, by contrast, sits at 0-2 with a 1-4 map tally following losses that highlighted struggles adapting to the current map pool and opponent aggression. The TvP matchup favors Cure’s recent form and head-to-head edge in similar group-stage settings, though sOs’s veteran Protoss experience keeps potential for map-specific upsets alive if early scouting or build variations disrupt Cure’s standard openers. No major roster or patch changes have altered the landscape in the days leading into the series.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedCure vs sOs
Moneyline
$110 Vol.
Map 1 Winner
$816 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: May 19, 2026, 6:00 PM ET
Resolution Source
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure vs sOs
Moneyline
$110 Vol.
Map 1 Winner
$816 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: May 19, 2026, 6:00 PM ET
Resolution Source
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure enters the best-of-three as the stronger recent performer in the 2026 GSL Season 2 group stage, sitting atop Group A with a 2-0 record and 4-1 map score after victories that showcased consistent Terran macro and timing attacks. sOs, by contrast, sits at 0-2 with a 1-4 map tally following losses that highlighted struggles adapting to the current map pool and opponent aggression. The TvP matchup favors Cure’s recent form and head-to-head edge in similar group-stage settings, though sOs’s veteran Protoss experience keeps potential for map-specific upsets alive if early scouting or build variations disrupt Cure’s standard openers. No major roster or patch changes have altered the landscape in the days leading into the series.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedBeware of external links.
Beware of external links.


Beware of external links.
Beware of external links.
Frequently Asked Questions